---
layout: default
---

## Publications

### A. Therapeutics

1. Mitjà, Oriol, *et al*. **Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial**, *Clinical Infectious Diseases*, 1058-4838, Jun, 2020, ([doi](https://doi.org/10.1093/cid/ciaa1009) / [ePrint](https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1009/33504392/ciaa1009.pdf)).

2. Mitjà, Oriol, *et al*. **A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease**, *The New England Journal of Medicine*, accepted for publication, ([doi](https://doi.org/10.1101/2020.07.20.20157651) / [ePrint](https://www.medrxiv.org/content/early/2020/07/26/2020.07.20.20157651.full.pdf)).

### B. Diagnostics

1. Alemany, Andrea, *et al*. **Analytical and Clinical Performance of the Panbio COVID-19 Antigen-Detecting Rapid Diagnostic Test**, submitted ([ePrint](draft_mecvrix.pdf)).

### C. Transmission

1. Marks, Michael, *et al*. **Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study**, submitted ([ePrint](transmission282.pdf)).

### D. Risk factors

1. Suñé, Clara, et al. **Risk factors for mortality of residents in nursing homes with Covid-19: a retrospective cohort study**, submitted ([ePrint](risk_residents.pdf)).
